Physician

Alaaeldin Mustafa, MD/DO

According to 2025 Medicare claims, Alaaeldin Mustafa, MD/DO (NPI: 1407317365) practices nephrology in the Camden, NJ market, with the plurality of this provider's patient population coming from Camden, NJ. This provider's primary affiliated billing organization is VIRTUA MEDICAL GROUP, PA (NPI: 1649226515; TIN: 271348772) and primary practice location at 08053-2177.

Mustafa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 163 traditional Medicare patients, billed 350 HCPCS/CPT codes, and received $27,326 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 144 prescription claims across 23 beneficiaries totaling $13,677 in drug costs, led by Chlorthalidone (Chlorthalidone). Open Payments data shows 1 records totaling $14. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have fallen sharply in recent years, from $14,912 to $13,677. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$14K$27K2024 Medicare payment: $27,326 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024163350$27,326

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$21K$42K2019 Drug cost: $14,912 (USD; Tot_Drug_Cst)2020 Drug cost: $28,550 (USD; Tot_Drug_Cst)2021 Drug cost: $42,372 (USD; Tot_Drug_Cst)2022 Drug cost: $35,703 (USD; Tot_Drug_Cst)2023 Drug cost: $1,612 (USD; Tot_Drug_Cst)2024 Drug cost: $13,677 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201923186$14,912
202058476$28,550
202152312$42,372
202244193$35,703
20231531$1,612
202423144$13,677

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes4141$142
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes3030$107
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes1316$97
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes109192$65
90935Hemodialysis procedure with physician evaluation4062$58

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ChlorthalidoneChlorthalidone451,470$666
Losartan PotassiumLosartan Potassium311,165$217

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$14Vifor Pharma, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alaaeldin Mustafa, MD/DO?

Tedicare shows public-source Medicare data for Alaaeldin Mustafa, MD/DO (NPI 1407317365), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alaaeldin Mustafa, MD/DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alaaeldin Mustafa, MD/DO?

Alaaeldin Mustafa, MD/DO is linked to VIRTUA MEDICAL GROUP, PA (billing NPI 1649226515) in the available physician profile data.

Does Alaaeldin Mustafa, MD/DO have Open Payments data?

Alaaeldin Mustafa, MD/DO has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.